Haiqing Yuan

This inventor holds 36 USPTO granted patents and 4 published patent applications and 11 EPO patents, primarily in Chemokine Receptor Modulators. Top assignees: Allergan, Inc., Victor Pharma Co., Ltd. Zhenjiang. Active years: 2004-2021.

USPTO Granted Patents = 36 (Patent Applications = 4)

% Patents Active = 61.1

EPO Patents = 11 (Patent Applications = 13)

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 76(Granted Patents)

Company Filing History:

Victor Pharma Co., Ltd. Zhenjiang

patent

Years Active: 2004-2021

Loading Chart...

Areas of Expertise:

Chemokine Receptor Modulators

Sulfur Derivatives

Sphingosine-1-Phosphate

Triamilide Derivatives

Benzofuran Derivatives

Indole Compounds

Prostaglandin Analogs

Heteroaromatic Compounds

Quinoline Derivatives

Naphthalene Derivatives

Bis-Sulfonamide Derivatives

Serum Glucose Reducing Activity

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11046644 - Sulfur derivatives as chemokine receptor modulators (2021-06-29),

2. 10287275 - 16-member triamilide derivatives and uses thereof (2019-05-14),

3. 10287243 - Sulfur derivatives as chemokine receptor modulators (2019-05-14),

4. 9670190 - Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators (2017-06-06),

5. 9663460 - Sulfur derivatives as chemokine receptor modulators (2017-05-30),

6. 9603834 - 1,2- bis-sulfonamide derivatives as chemokine receptor modulators (2017-03-28),

7. 9550746 - Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators (2017-01-24),

8. 9416120 - Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators (2016-08-16),

9. 9371278 - Sulfur derivatives as chemokine receptor modulators (2016-06-21),

10. 9328067 - Sulfur derivatives as chemokine receptor modulators (2016-05-03),

11. 8927544 - Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators (2015-01-06),

12. 8877804 - Sulfur derivatives as chemokine receptor modulators (2014-11-04),

13. 8822530 - Sulfur derivatives as chemokine receptor modulators (2014-09-02),

14. 8815915 - Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators (2014-08-26),

15. 8791161 - Sulfur derivatives as chemokine receptor modulators (2014-07-29),

Title: **Haiqing Yuan: Innovator in Pharmaceutical Chemistry**

Introduction

Haiqing Yuan is a highly accomplished inventor based in Irvine, California. With an impressive portfolio of 36 patents, his work has significantly impacted the field of pharmaceutical chemistry, particularly in the development of novel therapeutic compounds.

Latest Patents

Among his latest innovations are patents related to sulfur derivatives as chemokine receptor modulators. These patented inventions encompass novel sulfur derivatives, methods for their preparation, pharmaceutical compositions that include these compounds, and their application as pharmaceuticals targeting chemokine receptors. This work serves as a testament to Haiqing's expertise in creating innovative solutions in drug development.

Career Highlights

Throughout his career, Haiqing Yuan has worked with renowned companies such as Allergan, Inc. and Victor Pharma Co., Ltd. Zhenjiang. His contributions to these organizations highlight his adeptness in blending scientific research with practical applications in the pharmaceutical industry.

Collaborations

In addition to his individual accomplishments, Haiqing has collaborated with notable professionals in the field, including Richard L. Beard and John E. Donello. These partnerships reflect his commitment to advancing pharmaceutical research and developing groundbreaking medications.

Conclusion

Haiqing Yuan’s innovative work and extensive patent portfolio underscore his significant contributions to the world of pharmaceutical chemistry. As he continues to explore new avenues in drug development, his inventions are sure to influence future therapeutic strategies and improve patient outcomes.